There’s no apparent difference in efficacy or safety between anti-epileptic drugs diazepam and lorazepam in treating pediatric status epilepticus (SE)—a finding that challenges the results of some studies.
The frequency of migraine attacks is higher in women during perimenopause and postmenopause than in premenopause, a new study shows.
Despite comedians’ assertions to the contrary, sex-associated headaches are not funny. But medications can help relieve or even prevent them.
This debilitating disease has significant effects on family relationships as well as the person, a new study shows.
The Alzheimer drug may help repair some damage caused by stroke. In a rodent model, treated animals showed improved motor behavior and restored sensory mapping in the cortex. Here, more about the proposed mechanism.
The rate of diagnostic accuracy is lower in early disease and higher in later disease and is improved by medication response and other factors.
Recent studies are showing that patients with autoimmune associated epilepsy may respond favorably to immunosuppression and that many of affected patients lack the full-fledged syndromes that have received so much attention.
A new study puts a final nail in the coffin for the hypothesis that chronic cerebrospinal venous insufficiency is neither specific or causative for multiple sclerosis.
The remarkable coffee bean is associated with reduced prevalence of several diseases, including Parkinson disease, Alzheimer disease, cancer, cardiovascular disease, and diabetes.
This study indicates that your mother was right about eating your fruits and vegetables: results suggest that eating some foods and avoiding others could be a nutrient prescription for Parkinson disease.
In this study, high-dose simvastatin reduced the annualized rate of whole-brain atrophy in secondary progressive MS.
For people with MS, smoking is associated with more severe disease and faster disability progression. Smoking cessation before or after disease onset is associated with slower progression of disability.
Here: an update on the current state of CSF fluid-borne markers for Alzheimer disease and what they may portend.
Are you an MD who sees patients with neurological conditions and who likes to write? If so, we want you to write for this site!